Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
Current Oncology Reports
|
February 23, 2024
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?
Ilana Schlam, Joshua Dower, Filipa Lynce
Journal of the American College of Cardiology
|
June 8, 2019
Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All
Ana Barac, Anne Blaes, Filipa Lynce
Oncotargets and Therapy
|
May 5, 2022
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
Ilana Schlam, Raquel Nunes, Filipa Lynce
Current Breast Cancer Reports
|
December 25, 2018
Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer
Arielle Heeke, Maria Raquel Nunes, Filipa Lynce
Leukemia & Lymphoma
|
September 6, 2011
Obesity in adult lymphoma survivors
Filipa Lynce, Marieta Pehlivanova, Joseph Catlett, et al.
Journal of Medical Case Reports
|
December 14, 2012
Post-transfusion purpura in an African-American man due to human platelet antigen-5b alloantibody: a case report
Filipa Lynce, Fang Yin, Kirsten Alcorn, et al.
Circulation
|
February 20, 2019
Management of Cardiovascular Disease in Women With Breast Cancer
Rachel Barish, Filipa Lynce, Keith Unger, et al.
Pharmacology & Therapeutics
|
June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
Filipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
JACC. Cardiovascular Imaging
|
August 11, 2018
Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?
Chau T Dang, Anne Blaes, Filipa Lynce, et al.
Current Oncology Reports
|
January 10, 2024
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Fei Song, Paolo Tarantino, Ana Garrido-Castro, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
Current Oncology Reports
|
February 23, 2024
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?
Ilana Schlam, Joshua Dower, Filipa Lynce
Journal of the American College of Cardiology
|
June 8, 2019
Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All
Ana Barac, Anne Blaes, Filipa Lynce
Oncotargets and Therapy
|
May 5, 2022
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
Ilana Schlam, Raquel Nunes, Filipa Lynce
Current Breast Cancer Reports
|
December 25, 2018
Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer
Arielle Heeke, Maria Raquel Nunes, Filipa Lynce
Leukemia & Lymphoma
|
September 6, 2011
Obesity in adult lymphoma survivors
Filipa Lynce, Marieta Pehlivanova, Joseph Catlett, et al.
Journal of Medical Case Reports
|
December 14, 2012
Post-transfusion purpura in an African-American man due to human platelet antigen-5b alloantibody: a case report
Filipa Lynce, Fang Yin, Kirsten Alcorn, et al.
Circulation
|
February 20, 2019
Management of Cardiovascular Disease in Women With Breast Cancer
Rachel Barish, Filipa Lynce, Keith Unger, et al.
Pharmacology & Therapeutics
|
June 23, 2018
CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
Filipa Lynce, Ayesha N Shajahan-Haq, Sandra M Swain
JACC. Cardiovascular Imaging
|
August 11, 2018
Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?
Chau T Dang, Anne Blaes, Filipa Lynce, et al.
Current Oncology Reports
|
January 10, 2024
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Fei Song, Paolo Tarantino, Ana Garrido-Castro, et al.
Page
of 10